OPEN MARKET SALE AGREEMENTSMFusion Pharmaceuticals Inc. • July 2nd, 2021 • Biological products, (no disgnostic substances) • New York
Fusion Pharmaceuticals Inc., a corporation existing under the Canada Business Corporations Act (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), common shares in the capital of the Company (the “Common Shares”), having an aggregate offering price of up to $100,000,000 on the terms set forth in this agreement (this “Agreement”).
